Embree Financial Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.41M Sell
38,064
-8
-0% -$2.21K 0.84% 29
2026
Q1
$11.2M Sell
38,072
-5,951
-14% -$1.77M 1.32% 21
2025
Q4
$12M Sell
44,023
-3,919
-8% -$1.06M 1.47% 17
2025
Q3
$13M Sell
47,942
-273
-0.6% -$74.3K 1.74% 15
2025
Q2
$13.3M Sell
48,215
-1,996
-4% -$543K 2% 10
2025
Q1
$13.3M Sell
50,211
-718
-1% -$177K 2.23% 8
2024
Q4
$11.8M Hold
50,929
2.02% 9
2024
Q3
$11.2M Sell
50,929
-2,350
-4% -$486K 2% 9
2024
Q2
$10.5M Hold
53,279
2.01% 9
2024
Q1
$11.5M Buy
53,279
+21
+0% +$4.41K 2.25% 8
2023
Q4
$11.2M Buy
+53,258
New +$11.4M 2.36% 8

Other funds holding CME

Embree Financial Group's CME Position: Q2 2026 in Review

Embree Financial Group reduced its CME Group (CME) stake by 0.02% in Q2 2026, selling an estimated $2.21K and leaving 38,064 shares worth $8.41M. The position accounts for 0.84% of the portfolio, ranked #29.

Embree Financial Group first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.3M in Q1 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Embree Financial Group held 38,064 shares of CME Group worth $8.41M as of Q2 2026.
  • Embree Financial Group sold 8 CME Group shares in Q2 2026, an estimated $2.21K.
  • CME Group made up 0.84% of Embree Financial Group's portfolio in Q2 2026, its #29 holding.
  • Embree Financial Group first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Embree Financial Group's CME Group position peaked at $13.3M in Q1 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.